Axa S.A. I Teos Therapeutics, Inc. Transaction History

Axa S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$13.02 - $22.62 $6,457 - $11,219	-496 Reduced 0.23%	218,600 $2.98 Million
Q4 2022 Feb 14, 2023	SELL	$17.77 - $21.6 $21,075 - $25,617	-1,186 Reduced 0.54%	219,096 $4.28 Million
Q3 2022 Feb 14, 2023	BUY	$18.6 - $27.25 $1.03 Million - $1.51 Million	55,266 Added 33.49%	220,282 $4.2 Million
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $1.03 Million - $1.51 Million	55,266 Added 33.49%	220,282 $4.2 Million
Q2 2022 Feb 14, 2023	SELL	$16.57 - $35.1 $894,067 - $1.89 Million	-53,957 Reduced 24.64%	165,016 $3.4 Million
Q2 2022 Aug 15, 2022	SELL	$16.57 - $35.1 $894,067 - $1.89 Million	-53,957 Reduced 24.64%	165,016 $3.4 Million
Q1 2022 Feb 14, 2023	SELL	$31.92 - $47.45 $41,783 - $62,112	-1,309 Reduced 0.59%	218,973 $7.05 Million
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $63 - $94	2 Added 0.0%	218,973 $7.05 Million
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $68,565 - $125,106	2,614 Added 1.21%	218,971 $10.2 Million
Q3 2021 Nov 15, 2021	BUY	$23.91 - $29.58 $190,538 - $235,723	7,969 Added 3.82%	216,357 $5.84 Million
Q2 2021 Aug 13, 2021	BUY	$17.9 - $36.1 $1.52 Million - $3.06 Million	84,686 Added 68.46%	208,388 $5.35 Million
Q1 2021 May 14, 2021	BUY	$30.86 - $44.2 $3.82 Million - $5.47 Million	123,702 New	123,702 $4.23 Million

166

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $257M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.